Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 125

1.

The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation.

Xipell M, Rodas LM, Villarreal J, Molina A, Reinoso-Moreno J, Blasco M, Poch E, Diekmann F, Campistol JM, Quintana LF.

Clin Kidney J. 2018 Jun;11(3):422-428. doi: 10.1093/ckj/sfx128. Epub 2017 Nov 22.

2.

Acute tubulointerstitial nephritis associated with atezolizumab, an anti-programmed death-ligand 1 (pd-l1) antibody therapy.

Xipell M, Victoria I, Hoffmann V, Villarreal J, García-Herrera A, Reig O, Rodas L, Blasco M, Poch E, Mellado B, Quintana LF.

Oncoimmunology. 2018 Mar 26;7(7):e1445952. doi: 10.1080/2162402X.2018.1445952. eCollection 2018.

PMID:
29900063
3.

Cultural factors influencing antenatal depression: A cross-sectional study in a cohort of Turkish and Spanish women at the beginning of the pregnancy.

González-Mesa E, Kabukcuoglu K, Körükcü O, Blasco M, Ibrahim N, Kavas T.

J Affect Disord. 2018 Jun 2;238:256-260. doi: 10.1016/j.jad.2018.06.003. [Epub ahead of print]

PMID:
29890453
4.

Fibrates in primary prevention of cardiovascular disease. Comments on the results of a systematic review of the Cochrane Collaboration.

Brea A, Millán J, Ascaso JF, Blasco M, Díaz A, Hernández-Mijares A, Mantilla T, Pedro-Botet JC, Pintó X.

Clin Investig Arterioscler. 2018 Jul - Aug;30(4):188-192. doi: 10.1016/j.arteri.2018.04.002. Epub 2018 May 19. English, Spanish.

PMID:
29789212
5.

Fibrates in the secondary prevention of cardiovascular disease (infarction and stroke). Results of a systematic review and meta-analysis of the Cochrane collaboration.

Millan J, Pintó X, Brea A, Blasco M, Hernández-Mijares A, Ascaso J, Diaz A, Mantilla T, Pedro-Botet J.

Clin Investig Arterioscler. 2018 Jan - Feb;30(1):30-35. doi: 10.1016/j.arteri.2017.11.001. Epub 2018 Feb 1. English, Spanish.

PMID:
29395493
6.

Low temperature geothermal systems in carbonate-evaporitic rocks: Mineral equilibria assumptions and geothermometrical calculations. Insights from the Arnedillo thermal waters (Spain).

Blasco M, Gimeno MJ, Auqué LF.

Sci Total Environ. 2018 Feb 15;615:526-539. doi: 10.1016/j.scitotenv.2017.09.269. Epub 2017 Oct 5.

PMID:
28988088
7.

Respiratory polygraphy monitoring of intensive care patients receiving non-invasive ventilation.

Borsini E, Ernst G, Blanco M, Blasco M, Bosio M, Salvado A, Nigro C.

Sleep Sci. 2017 Jan-Mar;10(1):35-40. doi: 10.5935/1984-0063.20170006.

8.

A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.

Huerta A, Arjona E, Portoles J, Lopez-Sanchez P, Rabasco C, Espinosa M, Cavero T, Blasco M, Cao M, Manrique J, Cabello-Chavez V, Suñer M, Heras M, Fulladosa X, Belmar L, Sempere A, Peralta C, Castillo L, Arnau A, Praga M, Rodriguez de Cordoba S.

Kidney Int. 2018 Feb;93(2):450-459. doi: 10.1016/j.kint.2017.06.022. Epub 2017 Sep 12.

PMID:
28911789
9.

Clinical impact of regional citrate anticoagulation in continuous renal replacement therapy in critically ill patients.

Huguet M, Rodas L, Blasco M, Quintana LF, Mercadal J, Ortiz-Pérez JT, Rovira I, Poch E.

Int J Artif Organs. 2017 Nov 24;40(12):676-682. doi: 10.5301/ijao.5000633. Epub 2017 Aug 17.

PMID:
28862718
10.

Decalogue of the Spanish Society of Arteriosclerosis to reduce therapeutic inertia.

Blasco M, Pérez-Martínez P, Lahoz C.

Clin Investig Arterioscler. 2017 Sep - Oct;29(5):218-223. doi: 10.1016/j.arteri.2017.06.003. Epub 2017 Aug 26. English, Spanish.

PMID:
28844490
11.

Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.

Tortajada A, Gutiérrez E, Goicoechea de Jorge E, Anter J, Segarra A, Espinosa M, Blasco M, Roman E, Marco H, Quintana LF, Gutiérrez J, Pinto S, Lopez-Trascasa M, Praga M, Rodriguez de Córdoba S.

Kidney Int. 2017 Oct;92(4):953-963. doi: 10.1016/j.kint.2017.03.041. Epub 2017 Jun 19.

PMID:
28637589
12.

Thrombotic Microangiopathy: a Challenging Diagnosis Always.

Marco-Hernández J, Prieto-González S, Blasco M, Castro P, Cid J, Espinosa G.

Isr Med Assoc J. 2016 Jul;18(7):437-438. No abstract available.

13.

Eculizumab in secondary atypical haemolytic uraemic syndrome.

Cavero T, Rabasco C, López A, Román E, Ávila A, Sevillano Á, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, García A, Mendizabal S, Gavela E, Macía M, Quintana LF, María Romera A, Borrego J, Arjona E, Espinosa M, Portolés J, Gracia-Iguacel C, González-Parra E, Aljama P, Morales E, Cao M, Rodríguez de Córdoba S, Praga M.

Nephrol Dial Transplant. 2017 Mar 1;32(3):466-474. doi: 10.1093/ndt/gfw453.

14.

Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis.

Ascaso JF, Millán J, Hernández-Mijares A, Blasco M, Brea Á, Díaz Á, Mantilla T, Pedro-Botet J, Pintó X; Grupo de trabajo sobre Dislipemia Aterogénica de la SEA.

Clin Investig Arterioscler. 2017 Mar - Apr;29(2):86-91. doi: 10.1016/j.arteri.2016.11.001. Epub 2017 Feb 6. English, Spanish.

PMID:
28185675
15.

Pectinase production by Aspergillus giganteus in solid-state fermentation: optimization, scale-up, biochemical characterization and its application in olive-oil extraction.

Ortiz GE, Ponce-Mora MC, Noseda DG, Cazabat G, Saravalli C, López MC, Gil GP, Blasco M, Albertó EO.

J Ind Microbiol Biotechnol. 2017 Feb;44(2):197-211. doi: 10.1007/s10295-016-1873-0. Epub 2016 Nov 22.

PMID:
27878454
16.

Induced parthenogenesis by gamma-irradiated pollen in loquat for haploid production.

Blasco M, Badenes ML, Del Mar Naval M.

Breed Sci. 2016 Sep;66(4):606-612. Epub 2016 Aug 5.

17.

Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease.

Brea Á, Pintó X, Ascaso JF, Blasco M, Díaz Á, González-Santos P, Hernández Mijares A, Mantilla T, Millán J, Pedro-Botet J; Grupo de trabajo sobre Dislipemia Aterogénica. Sociedad Española de Arteriosclerosis.

Clin Investig Arterioscler. 2017 May - Jun;29(3):141-148. doi: 10.1016/j.arteri.2016.06.003. Epub 2016 Sep 28. English, Spanish.

PMID:
27692633
18.

Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease.

Brea Á, Pintó X, Ascaso JF, Blasco M, Díaz Á, González-Santos P, Hernández-Mijares A, Mantilla T, Millán J, Pedro-Botet J; Grupo de trabajo sobre Dislipemia Aterogénica, Sociedad Española de Arteriosclerosis.

Clin Investig Arterioscler. 2017 Jul - Aug;29(4):185-200. doi: 10.1016/j.arteri.2016.06.002. Epub 2016 Sep 28. English, Spanish.

PMID:
27692632
19.

[The real measurement of non-HDL-cholesterol: Atherogenic cholesterol].

Millán J, Hernández-Mijares A, Ascaso JF, Blasco M, Brea A, Díaz Á, González-Santos P, Mantilla T, Pedro-Botet J, Pintó X; Grupo de trabajo sobre Dislipemia Aterogénica. Sociedad Española de Arteriosclerosis.

Clin Investig Arterioscler. 2016 Nov - Dec;28(6):265-270. doi: 10.1016/j.arteri.2016.05.002. Epub 2016 Sep 12. Spanish.

PMID:
27633523
20.

[Fibrates therapy: Rational use fenofibrate 2016. Executive summary].

Brea A, Millán J, Ascaso JF, Blasco M, Díaz A, González-Santos P, Hernández-Mijares A, Mantilla T, Pedro-Botet JC, Pintó X; en nombre del Foro de la Dislipemia Aterogénica.

Clin Investig Arterioscler. 2016 Nov - Dec;28(6):295-301. doi: 10.1016/j.arteri.2016.06.001. Epub 2016 Sep 5. Spanish.

PMID:
27609708

Supplemental Content

Loading ...
Support Center